Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Earnings To Watch: United Community Banks Inc (UCB) Reports Q3 2024 Result
United Community Banks Inc (NYSE:UCB) is set to release its Q3 2024 earnings on Oct 23, 2024. The consensus estimate for Q3 2024 revenue is $247.82 million, and the earnings are expected to come in at $0.
United Community Banks price target lowered to $30 from $32 at Truist
Truist lowered the firm’s price target on United Community Banks (UCB) to $30 from $32 and keeps a Hold rating on the shares as part of
United Community Banks (UCB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2024, United Community Banks (UCB) reported revenue of $244.49 million, up 4.3% over the same period last year. EPS came in at $0.57, compared to $0.45 in the year-ago quarter.
United Bankshares: Q3 Earnings Snapshot
The bank, based in Charleston, West Virginia, said it had earnings of 70 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 68 cents per share.
D.A. Davidson Keeps Their Buy Rating on United Community Banks (UCB)
D.A. Davidson analyst Gary Tenner maintained a Buy rating on United Community Banks (UCB – Research Report) today and set a price target
United Community Banks, Inc. (UCB) Q3 2024 Earnings Call Transcript
Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the call today are Chairman and Chief Executive Officer Lynn Harton, Chief Financial Officer Jefferson Harralson,
United Community Banks: Q3 Earnings Snapshot
The Greenville, South Carolina-based bank said it had earnings of 38 cents per share. Earnings, adjusted for one-time gains and costs, came to 57 cents per share. The results missed Wall Street expectations.
FierceBiotech
2d
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...
The Pharma Letter
2d
UCB reveals Roche deal on bepranemab terminated
UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...
7d
Bimzelx Powers UCB To New Heights: Deep Dive Into The Company's Growth Strategy
UCB SA has a promising drug, Bimzelx, despite temporary EBITDA decline and potential regulatory hurdles ahead. Learn more ...
Hosted on MSN
17h
United Community Banks, Inc. (NYSE:UCB) Q3 2024 Earnings Call Transcript
United Community Banks, Inc. (NYSE:
UCB
) Q3 2024 Earnings Call Transcript October 23, 2024 Operator: Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the ...
BioSpace
2d
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...
BioPharma Dive
1d
Merck acquires cancer drug startup; Elevidys ex-US sales rise
Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...
news.stocktradersdaily
7d
(UCB) Trading Report
October 17, 2024, 13:48 pm ET, BY Jolene W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short UCB slightly ...
The Daily Star
17h
Monash College Diploma’s third intake orientation held at UCB
UCB recently hosted the orientation programme for this year’s third intake of the Monash College Diploma programme.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
United Community Bank
Roche
Alzheimer's disease
Genentech
Feedback